Piribedil Impurity 11 | CAS 2591-25-5 - Request Quote
Piribedil Impurity 11
| SZ CAT No: | SZ-P158015 |
| CAS No | 2591-25-5 |
| Mol.F. | C8H7ClO3 |
| Mol.Wt. | 186.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Piribedil Impurity 11 is chemically (6-Chlorobenzo[d][1,3]dioxol-5-yl)methanol. Piribedil Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Piribedil Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Piribedil.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2591-25-5
Purchase 2591-25-5
Order 2591-25-5
Enquire 2591-25-5
price of 2591-25-5
2591-25-5 Supplier
2591-25-5 Manufacturer
2591-25-5 Exporter
buy high quality Piribedil Impurity 11
Purchase Piribedil Impurity 11
Piribedil Impurity 11 suppliers
Piribedil Impurity 11 manufacturers
Piribedil Impurity 11 price
Order Piribedil Impurity 11
Enquire Piribedil Impurity 11
Piribedil Impurity 11 cost
Piribedil Impurity 11 Supplier
Piribedil Impurity 11 Distributor
Piribedil Impurity 11 for Method Validation
Piribedil Reference Standard
Piribedil Impurity 11 for ANDA Filing
Piribedil Impurity 11 for Forced Degradation Studies
Piribedil Impurity 11 Identification Standards
Piribedil Impurity 11 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


